HIV in breast milk can be drug resistant | Science News

ADVERTISEMENT

MISSION CRITICAL

Support credible science journalism.

Subscribe to Science News today.


News

HIV in breast milk can be drug resistant

By
12:43pm, February 25, 2003

From Boston, at a conference on Retroviruses and Opportunistic Infections

A drug called nevirapine, sold as Viramune, can reduce the risk of mother-to-newborn transmission of HIV when taken by a woman at the onset of labor. Scientists now report that after taking nevirapine, the women often harbor a form of HIV with genetic mutations that make it resistant to the drug. Moreover, the mutant virus is more prevalent in the breast milk of infected women than in their blood.

The finding suggests that these women could be passing along resistant forms of the virus to their children during breast-feeding, says Esther Lee of Stanford University. HIV-infected mothers who choose to breastfeed have about a one-in-six chance of transmitting the virus to their babies via breast milk.

This article is available only to subscribing members. Join the Society today or Log in.

Get Science News headlines by e-mail.

More from this issue of Science News

[title_1]
From the Nature Index Paid Content